75 related articles for article (PubMed ID: 20132171)
1. AMACR is not applicable as a diagnostic tool in hepatocellular carcinoma.
Willemoe GL; Vainer B
APMIS; 2010 Feb; 118(2):85-90. PubMed ID: 20132171
[TBL] [Abstract][Full Text] [Related]
2. Role of alpha methylacyl-coenzyme A racemase in differentiating hepatocellular carcinoma from dysplastic and nondysplastic liver cell lesions.
Helal Tel A; Radwan NA; Abdel Kader Z; Helmy NA; Hammad SY
Ann Diagn Pathol; 2012 Oct; 16(5):330-4. PubMed ID: 22542076
[TBL] [Abstract][Full Text] [Related]
3. Alpha-methylacyl-CoA racemase (P504S)/34betaE12/p63 triple cocktail stain in prostatic adenocarcinoma after hormonal therapy.
Sung MT; Jiang Z; Montironi R; MacLennan GT; Mazzucchelli R; Cheng L
Hum Pathol; 2007 Feb; 38(2):332-41. PubMed ID: 17134736
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of alpha-methylacyl-coenzyme A racemase in colorectal carcinoma bears clinical and pathologic significance.
Lin A; Weiser MR; Klimstra DS; Paty PB; Tang LH; Al-Ahmadie H; Hoo Park S; Guillem JG; Temple L; Wong WD; Gerald WL; Shia J
Hum Pathol; 2007 Jun; 38(6):850-6. PubMed ID: 17442371
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical antibody cocktail staining (p63/HMWCK/AMACR) of ductal adenocarcinoma and Gleason pattern 4 cribriform and noncribriform acinar adenocarcinomas of the prostate.
Herawi M; Epstein JI
Am J Surg Pathol; 2007 Jun; 31(6):889-94. PubMed ID: 17527076
[TBL] [Abstract][Full Text] [Related]
6. Alpha-methylacyl-CoA racemase (AMACR/P504S) can distinguish hepatocellular carcinoma and dysplastic hepatocytes from benign nondysplastic hepatocytes.
Guzman G; Wu SJ; Kajdacsy-Balla A; Cotler SJ
Appl Immunohistochem Mol Morphol; 2006 Dec; 14(4):411-6. PubMed ID: 17122637
[TBL] [Abstract][Full Text] [Related]
7. Significance of overexpression of alpha methylacyl-coenzyme A racemase in hepatocellular carcinoma.
Li W; Cagle PT; Botero RC; Liang JJ; Zhang Z; Tan D
J Exp Clin Cancer Res; 2008 May; 27(1):2. PubMed ID: 18577240
[TBL] [Abstract][Full Text] [Related]
8. AMACR immunostaining is useful in detecting dysplastic epithelium in Barrett's esophagus, ulcerative colitis, and Crohn's disease.
Dorer R; Odze RD
Am J Surg Pathol; 2006 Jul; 30(7):871-7. PubMed ID: 16819330
[TBL] [Abstract][Full Text] [Related]
9. Alpha-methylacyl-CoA racemase: a new molecular marker for prostate cancer.
Luo J; Zha S; Gage WR; Dunn TA; Hicks JL; Bennett CJ; Ewing CM; Platz EA; Ferdinandusse S; Wanders RJ; Trent JM; Isaacs WB; De Marzo AM
Cancer Res; 2002 Apr; 62(8):2220-6. PubMed ID: 11956072
[TBL] [Abstract][Full Text] [Related]
10. Alpha-methylacyl-CoA-racemase expression in adenocarcinoma, dysplasia and non-neoplastic epithelium of the stomach.
Lee WA
Oncology; 2006; 71(3-4):246-50. PubMed ID: 17652945
[TBL] [Abstract][Full Text] [Related]
11. Alpha-methylacyl-CoA racemase protein expression is associated with the degree of differentiation in breast cancer using quantitative image analysis.
Witkiewicz AK; Varambally S; Shen R; Mehra R; Sabel MS; Ghosh D; Chinnaiyan AM; Rubin MA; Kleer CG
Cancer Epidemiol Biomarkers Prev; 2005 Jun; 14(6):1418-23. PubMed ID: 15941950
[TBL] [Abstract][Full Text] [Related]
12. Alpha-methylacyl-CoA racemase (P504S) expression in evolving carcinomas within benign prostatic hyperplasia and in cancers of the transition zone.
Leav I; McNeal JE; Ho SM; Jiang Z
Hum Pathol; 2003 Mar; 34(3):228-33. PubMed ID: 12673556
[TBL] [Abstract][Full Text] [Related]
13. Altered expression of alpha-methylacyl-coenzyme A racemase in prostatic adenocarcinoma following hormone therapy.
Suzue K; Montag AG; Tretiakova M; Yang XJ; Sahoo S
Am J Clin Pathol; 2005 Apr; 123(4):553-61. PubMed ID: 15743746
[TBL] [Abstract][Full Text] [Related]
14. Abundant expression of AMACR in many distinct tumour types.
Went PT; Sauter G; Oberholzer M; Bubendorf L
Pathology; 2006 Oct; 38(5):426-32. PubMed ID: 17008281
[TBL] [Abstract][Full Text] [Related]
15. Alpha-methylacyl-CoA racemase (AMACR) expression in normal prostatic glands and high-grade prostatic intraepithelial neoplasia (HGPIN): association with diagnosis of prostate cancer.
Ananthanarayanan V; Deaton RJ; Yang XJ; Pins MR; Gann PH
Prostate; 2005 Jun; 63(4):341-6. PubMed ID: 15602744
[TBL] [Abstract][Full Text] [Related]
16. Alpha-methylacyl-CoA racemase (AMACR) in fine-needle aspiration specimens of prostate lesions.
Kaić G; Tomasović-Loncarić C
Diagn Cytopathol; 2009 Nov; 37(11):803-8. PubMed ID: 19459159
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneous expression of alpha-methylacyl-CoA racemase in prostatic cancer correlates with Gleason score.
Murphy AJ; Hughes CA; Lannigan G; Sheils O; O'Leary J; Loftus B
Histopathology; 2007 Jan; 50(2):243-51. PubMed ID: 17222253
[TBL] [Abstract][Full Text] [Related]
18. Expression of c-kit protooncogen in hepatitis B virus-induced chronic hepatitis, cirrhosis and hepatocellular carcinoma: has it a diagnostic role?
Kara B; Doran F; Kara IO; Akkiz H; Sandikci M
Int J Clin Pract; 2008 Aug; 62(8):1206-11. PubMed ID: 18284441
[TBL] [Abstract][Full Text] [Related]
19. Discovery and clinical application of a novel prostate cancer marker: alpha-methylacyl CoA racemase (P504S).
Jiang Z; Woda BA; Wu CL; Yang XJ
Am J Clin Pathol; 2004 Aug; 122(2):275-89. PubMed ID: 15323145
[TBL] [Abstract][Full Text] [Related]
20. The prostate-specific G-protein coupled receptors PSGR and PSGR2 are prostate cancer biomarkers that are complementary to alpha-methylacyl-CoA racemase.
Wang J; Weng J; Cai Y; Penland R; Liu M; Ittmann M
Prostate; 2006 Jun; 66(8):847-57. PubMed ID: 16491480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
